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Abstract
Introduction: Hypotensive episodes are a common complication of spinal
anesthesia during Cesarean section. The purpose of this study was to compare
the effectiveness and the side effects of vasopressors, ephedrine and
phenylephrine, administered for hypotension during elective Cesarean section
under spinal anesthesia.
Material and methods: The study consisted of 100 selected ASA I/II females
scheduled for elective Cesarean section under spinal anesthesia. Each patient
was randomly assigned to one of the two double-blind study groups. Group E
received 1 ml ephedrine (5 mg/ml) with normal saline if hypotension was present
(n = 50). Group P received 1 ml phenylephrine (100 µg/ml) with normal saline
if hypotension developed (n = 50). Heart rate (HR), systolic blood pressure (SBP),
diastolic blood pressure (DBP), mean arterial pressure (MAP) were compared
within and between groups to basal levels at time increments of 0, 2, 4, 6, 8,
10, 15, 20, 25, 30, 45, and 60 min from start of surgery. Incidence of side effects
and neonatal outcomes were studied between groups.
Results:  All patients required vasopressor therapy for hypotension.
Administration of phenylephrine was associated with significant drop in HR.
Changes in SBP, DBP, and MAP were similar in both groups for most observed
times. The incidences of nausea/vomiting and tachycardia were significantly
higher in the ephedrine group. 
Conclusions: Phenylephrine and ephedrine are acceptable choices to combat
maternal hypotension related to spinal anesthesia in elective Cesarean section.
Complications of intra-operative nausea and vomiting, tachycardia and
bradycardia should be considered when choosing a vasopressor, suggesting
phenylephrine may be more appropriate when considering maternal well-being.
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Introduction
Cesarean section is one of the most commonly performed operations.
Many countries have seen increases in their rates due to factors such as
widespread use of fetal monitoring, high private insurance rates, restrictive
insurance policies, advancing maternal age and high medical malpractice
costs [1-4]. With the large number of women undergoing this procedure,
it is necessary to consider the inherent risks involved for both mother and
child. General anesthesia has generally fallen out of favor in the
international community for elective Cesarean sections. Increased risk to
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the fetus from the anesthetic drugs, maternal
airway management and post-operative effects are
well documented, though it is still used for
emergency surgery [5-8]. Avoidance of the risks
inherent in general anesthesia is crucial for
improved maternal and fetal outcome [6, 9].
Regional anesthesia in Cesarean section offers
significant benefit over general anesthesia. Epidural
anesthesia provides the opportunity to extend
surgical anesthesia to post-surgical analgesia via
catheter and control of the level of anesthesia. Spinal
anesthesia is inexpensive and yields symmetric block
rapidly. Combined spinal-epidural anesthesia offers
the benefit of both epidural and spinal techniques
with less medication, better reliability and less
incidence of hypotension [10, 11]. However, regional
anesthesia in Cesarean section is not without
complication. Supine hypotension syndrome due to
aortocaval compression could deteriorate the
hemodynamic effect of spinal anesthesia [12, 13]. The
risk to the mother includes symptoms of dizziness,
nausea and vomiting due the rapid decline in blood
pressure, while fetal acidosis may be among the fetal
consequences of prolonged maternal hypotension
[11, 14]. To prevent injury to mother or fetus caused
by hypotension, it is customary to treat supine
hypotension syndrome quickly and efficiently.
Routinely, vasopressors such as ephedrine,
metaraminol, and phenylephrine have been given
prophylactically and preoperatively to combat
maternal hypotension [15-18]. Until recently,
ephedrine has been the vasopressor used most often
in North America as it reliably prevents maternal
hypotension, while mephentermine is used
commonly in many Asian countries including India
[11, 19]. Conversely, ephedrine has been implicated
in lower umbilical pH levels, especially when used in
dosages high enough to stem nausea and vomiting
related to hypotension [20, 21]. Recent studies have
indicated a decrease in side effects related to
vasopressors, such as nausea and vomiting, and
increased uteroplacental blood flow with the use of
phenylephrine [17, 22]. Phenylephrine, an α-agonist,
has been found to be detrimental to the well-being
of the fetus based on numerous animal models [16,
23, 24]. However, studies have begun to question the
application of the results of animal models to human
clinical practice due to physiological species
differences [16, 22, 25, 26]. The purpose of this study
was to investigate the effectiveness and the side
effects of intravenous phenylephrine and ephedrine
in combating maternal hypotension resulting from
spinal anesthesia in patients undergoing elective
Cesarean section.
Material and methods
This study was performed at K.R. Hospital,
Government Medical College, Rajiv Gandhi
University of Health Sciences (Karnataka state,
India), during 2007-2008, after institutional approval
was granted from the hospital’s ethical and
scientific committees. Informed consent was
obtained from 100 female patients, ASA I/II status,
scheduled for elective Cesarean section under
spinal anesthesia. 
Study design
Each patient was randomly assigned to one of
the two double-blind study groups. The Group E
received 1 ml ephedrine, 50 mg diluted to 10 ml 
(5 mg/ml), with normal saline if hypotension was
present. The Group P was given 1 ml phenylephrine,
1 mg diluted to 10 ml (100 µg/ml), with normal
saline if hypotension was present. Blood pressure,
oxygen saturation, pulse rate, and respiratory rate
were monitored every 2 min for the first 10 min,
every 5 min from 10 to 30 min and every 15 min
from 30 to 60 min. Times of baby extraction,
vasopressor administration and duration of surgery
were recorded. Neonatal monitoring was performed
by attending neonatologist at 1 and 5 min using
APGAR scoring rubric [27].
Pre-surgical protocol
Prior to surgery each patient was examined and
a thorough medical history taken with emphasis
on respiratory and cardiovascular systems. Potential
participants with diabetes mellitus, hypertension,
pulmonary tuberculosis, drug allergies, bronchial
asthma, epilepsy and bleeding disorders were
excluded from the study. A history of pregnancy-
induced hypertension and gestational diabetes,
symptoms and signs of antepartum hemorrhage
by placenta previa and abruption placenta were
considered exclusion criteria. All patients received
10 ml/kg of ringer lactate for pre loading. Intra-
operatively around 1000-1500 ml of normal saline
was infused to the patients. In ephedrine group,
92% of patients received a total dose of 5 mg of
ephedrine (single bolus) and 8% of patients
received a total dose of 10 mg of ephedrine 
(2 boluses). In phenylephrine group, 94% of patients
received a total dose of 100 µg of phenylephrine
(single bolus) and 6% of patients received a total
dose of 200 µg of phenylephrine (2 boluses).
Surgical protocol
On the day of surgery, patients were pre-
medicated with a single injection of metoclopra  -
mide 10 mg and a single injection of ranitidine
50 mg IV one hour prior to surgery. Both groups
were pre-loaded with RL 10 ml/kg 20 min before
spinal anesthetic procedure. Patients were
positioned in the right lateral position with flexion
of thigh and legs, hip and knees and flexion at theArch Med Sci 2, April / 2010 259
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head. The operating table was kept flat. Using
aseptic precautions, lumbar puncture was
performed at L3-4 using midline approach with 23G
sterile Quinke’s needle. After visualization of clear
and free flow of cerebrospinal fluid (CSF),
bupivacaine 0.5% heavy, 1.6 ml bolus was injected
into L3-4 subarachnoid space. Patients were turned
to supine position with a wedge under the right
buttock. After recording preoperative (basal) heart
rate (HR), systolic blood pressure (SBP), diastolic
blood pressure (DBP), mean arterial pressure (MAP),
and SPO2 patients were monitored according to the
protocol as indicated in the study design section. If
hypotension occurred, defined as a fall of systolic
blood pressure ≤ 90 mm Hg and/or 30% less than
the basal SBP, patients were given either
phenylephrine or ephedrine by anesthesiologist
who was blinded about the drug in the syringe.
Time of vasopressor administration, duration of
surgery, and time of neonate extraction were
recorded as minutes after start of surgery. All
incidences of bradycardia (HR < 60 bpm) were
treated with atropine 0.5 mg IV; any tachycardia (HR
> 30% above the basal HR) was noted. Intra-
operative nausea and vomiting were recorded. After
baby extraction, all patients received 20 units
oxytocin by infusion through a separate line.
Neonatal well-being was assessed by attending
neonatologist. Patients were monitored
postoperatively for 24 h for adverse effects.
Statistical analysis
Summary statistics of age, weight, height for
both “P” group and “E” group were reported as
means ± standard deviation. Intra- and inter-group
analysis for HR, SBP, DBP, and MAP were
statistically evaluated using one-way ANOVA and
paired  t-tests using both StatPlus™ v2, and
Minitab™, where p < 0.05 was considered
significant and p < 0.001 highly significant.
Complications of nausea, vomiting, tachycardia and
bradycardia were evaluated with the Fisher’s exact
test, where p < 0.05 was considered significant and
p < 0.001 highly significant.
Results
Overall, the demographic characteristics of both
groups were similar. There were no statistical
differences between the groups with respect to age,
weight, or height (Table I). All patients required
vasopressor therapy for hypotension. In our study,
top-off doses of vasopressor for repeat hypotension
were comparable between groups (6% in group P,
8% in group E). Decline from the basal heart rate
was observed in phenylephrine (P) group but was
not significant across all measured times (Figure 1).
An increase in heart rate from basal levels was seen
in ephedrine (E) group across all times and this was
significant at each time. The mean maximum heart
rate recorded after vasopressor administration was
Ephedrine group means (SD) Phenylephrine group means (SD) P-value
Age [years] 24.08 (3.74) 23.38 (3.54) 0.169
Weight [kg] 54.84 (6.28) 56.42 (4.70) 0.086
Height [cm] 150.74 (4.49) 151.1 (3.55) 0.344
Duration of surgery [min] 47.4 (3.81) 45.3 (3.70) < 0.001
Time of baby extraction [min] 6.24 (2.06) 6.28 (2.94) 0.45
Data expressed as mean (SD)
Table I. Demographic characteristics and operation data between groups
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Figure 1.A– Mean heart rate (HR) values for ephedrine and phenylephrine mean ± SD, and B – percent difference
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significantly higher in group E than in group P 
(t = 3.06, p < 0.05) (Table II). Furthermore,
administration of phenylephrine was associated
with a highly significant drop in heart rate (t = 6.68,
p ≤ 0.001) (Table III). Six patients in the P group
required atropine for the treatment of bradycardia
and responded favorably. The maximum and
minimum systolic blood pressures after vasopressor
bolus were higher in group P, though the
differences were not statistically significant. No
significant difference in SBP between the groups
was recorded at all measured points except at
T = 4 min (Figure 2), when SBP of patients in group
E was significantly lower than SBP of patients in
group P (t = –2.85, p < 0.05). Diastolic blood
pressure was comparable between the ephedrine
and phenylephrine groups for all measured times
except at T = 2 min, when P group DBP was
significantly lower than E group DBP (t = 2.53, 
p < 0.05) (Figure 2). Beginning at T = 4 min, MAP
values between the groups was similar and not
significant (p > 0.05). Overall, phenylephrine was
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Ephedrine group means (SD) Phenylephrine group means (SD) P-value
Time of vasopressor  4.52 (4.25) 3.48 (3.72) < 0.05
administration [min]
Maximum HR after vasopressor  110.84 (12.89) 103.06 (11.51) < 0.05
administration [beats/min]
Minimum HR after vasopressor  90.48 (12.87) 73.46 (11.29) < 0.001
administration [beats/min]
Maximum SBP after vasopressor  124.96 (8.18) 126.52 (8.21) 0.18
administration [mm Hg]
Minimum SBP after vasopressor  99.72 (20.74) 104.16 (7.50) 0.09
administration [mm Hg]
Data expressed as mean (SD), HR – heart rate, SBP – systolic blood pressure
Table II. Time of vasopressor administration and the following hemodynamic values between groups
Time  Ephedrine  Phenylephrine  P-value
[min]g roup means  group means 
(SD) [beats/min] (SD) [beats/min]
Basal 92.86 (13.22) 92.62 (10.79) 0.47
0 96.14 (12.42) 95.22 (12.12) 0.36
2 95.68 (11.88) 93.56 (13.20) 0.22
4 97.62 (13.38) 82.86 (18.23) < 0.001
6 99.50 (15.88) 85.50 (14.91) < 0.001
8 99.84 (13.98) 88.30 (14.69) < 0.001
10 101.20 (13.34) 93.32 (13.75) < 0.005
15 102.86 (12.96) 94.98 (11.76) < 0.005
20 101.90 (12.90) 97.14 (12.23) < 0.05
25 103.00 (12.90) 98.54 (12.10) < 0.05
30 101.70 (13.02) 97.36 (11.92) 0.06
45 100.00 (11.42) 96.88 (10.37) 0.10
60 98.76 (11.05) 96.18 (10.03) 0.12
Data are expressed as mean value (SD)
Table III. Mean heart rate values 
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Figure 2.A– Mean systolic blood pressure values for ephedrine and phenylephrine mean ± SD and B – mean diastolic
blood pressure values for ephedrine and phenylephrine mean ± SD
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associated with a significantly higher increase in
systolic blood pressure (t = 1.89, p < 0.05) and mean
arterial pressure (t = 1.92, p < 0.05). In our study, 
38 patients in ephedrine group and 36 patients in
phenylephrine group had an upper level of sensory
analgesia of T4-5. Twelve patients in ephedrine
group and 14 patients in phenylephrine group had
upper level of sensory analgesia of T6-7. The sensory
level attained in both groups was therefore
comparable and not significant (p > 0.08).
Complications
While 9 patients (18%) in the ephedrine group
exhibited nausea, only 4 patients (8%) in the
phenylephrine group experienced nausea (Table IV).
In the ephedrine group, 7 patients (14%) vomited,
while none (0%) exhibited this symptom in the
phenylephrine group. The incidence of vomiting
between groups is statistically significant (p < 0.05).
The number of patients with bradycardia was
higher in the phenylephrine group, however all
patients with bradycardia responded well to
atropine. The administration of phenylephrine
caused bradycardia in 12% of patients which was
not significant (p > 0.05), while ephedrine was seen
to cause tachycardia in 16% of patients which was
significant (p < 0.05) (Table IV). In ephedrine group
only one patient had bradycardia and this patient
had an upper sensory level of T3. In Phenylephrine
group six patients had bradycardia and these
patients had level of T5-6. 
APGAR scores
APGAR scores of all neonates were satisfactory
at birth. All babies in “E” group had APGAR scores
between 8-9 at 1 min and 10 at 5 min. All babies in
group “P” had APGAR scores between 8-9 at 1 min
and 10 at 5 min. The results were comparable for
both groups. 
Discussion
This study demonstrated that phenylephrine and
ephedrine are comparable vasopressors when used
to treat hypotension during an elective Cesarean
section. The significant difference in heart rate
between groups can primarily be attributed to the
decline in heart rate associated with phenylephrine
and the increase in heart rate associated with
ephedrine. Despite the significant decline in heart
rate observed with phenylephrine, it provided better
attenuation of heart rate than ephedrine for all
measured time points except T = 4 min and
T = 6 min. Bradycardia is usually seen with
phenylephrine usage because of its well known 
α-agonist properties [28]. The incidence of tachycardia
was significantly higher in the ephedrine group,
possibly due to difficulty in accurate titration of
ephedrine because of its initial slow response and
longer duration of action. Our results are in
agreement with a number of other studies where
significant tachycardia was observed with ephedrine
usage [15, 28]. However, Loughery’s et al. [29] found
no cases of rebound hypertension with ephedrine,
while Magalhaes et al. [30] reported comparable
numbers of both bradycardia and reactive
hypertension with ephedrine and phenylephrine.
Furthermore, incidence of fetal tachycardia with
ephedrine was reported significant in another study
[11]. Though fetal heart rate was not measured in
this study, the incidence of maternal tachycardia
with ephedrine was significant.
Spinal anesthesia was associated with
hypotension in all patients in both groups. However,
nausea and/or vomiting occurred in only 8% of
patients in the phenylephrine group compared to
18% of patients in the ephedrine group. Our results
are in concurrence with a number of recent studies
indicating a significantly higher incidence of
nausea/vomiting with ephedrine usage [19, 22, 29].
Nevertheless, Magalhaes et al. [30] reported
a higher prevalence of nausea/vomiting in patients
who received phenylephrine compared to those
who received ephedrine. In all cases, administration
of a second dose of vasopressor resulted in
occurrence of nausea and/or vomiting. Furthermore,
the maximum drop in systolic blood pressure was
higher in the phenylephrine group than the
ephedrine group, yet fewer incidences of
nausea/vomiting occurred. We calculated the
maximum drop from one time interval to the next
measured time interval for each patient, then
grouped them by whether or not they had
nausea/vomiting. This suggests that the
vasopressor choice may be more significant than
the level of hypotension in predicting side effects.
In addition, only one patient had bradycardia in
ephedrine group, this patient had an upper sensory
level of T3, compared six patients in phenylephrine
group; these patients had upper sensory level of
T5-6. Thus the bradycardia observed in ephedrine
group may be due to activation of Bain Bridge reflex
and involvement of cardio acceleratory fibers. In
phenylephrine group, the bradycardia may be due
Ephedrine  Phenylephrine P-value
group, n (%)g roup, n (%)
Nausea 9 (18%) 4 (8%) 0.08
Vomiting 7 (14%) 0 (0%) < 0.05
Bradycardia 1 (2%) 6 (12%) 0.05
Tachycardia 8 (16%) 0 (0%) < 0.05
5 min Apgar < 7 0 (0%) 0 (0%) 1.0 
Data expressed as number of patients (n) (%)
Table IV. Number of complications between groupsChandrakala P . Gunda, Jennifer Malinowski, Aruna Tegginmath, Venkatesh G. Suryanarayana, Sathees B.C. Chandra
to combination of Bain Bridge reflex and reflex
bradycardia due to administration of phenylephrine.
Many studies have attempted to determine the
best vasopressor during spinal anesthesia in
elective and non-elective Cesarean section using
both animal and human subjects [15, 18-20, 24, 28,
30-33]. Ephedrine has been used as a primary
vasopressor in obstetric patients for years based
on its efficacy in returning maternal systolic blood
pressure to a normal reading during spinal
anesthesia during Cesarean section. Ephedrine
indirectly raises blood pressure by increasing the
release of norepinephrine [11]. Since the 1960s,
several studies on chronically instrumented sheep
have suggested that ephedrine is a better choice
as a vasopressor than phenylephrine, mephen  -
termine, methoxamine or metaraminol [16, 24, 31,
34]. In pregnant ewes, ephedrine has not been
shown to decrease blood flow to the uterus.
Additionally, use of ephedrine returned fetal
cardiovascular hemodynamics to baseline after
maternal hypotension in a sheep model [16] and
may prevent fetal late decelerations [11]. However,
a number of studies have identified a decrease in
fetal umbilical pH after administration of ephedrine
[20, 30]. This again corroborates the conclusions
drawn from extensive review article by Lee et al.
[28] that fetal umbilical pH was lower in parturients
who received ephedrine than in those who received
phenylephrine. Furthermore, phenylephrine has been
used for quite some time as an alternative agent for
the treatment of hypotension after spinal anesthesia
in Cesarean sections or in cases where ephedrine was
ineffective [21, 33]. Animal models with compromised
fetuses suggest that phenylephrine does not increase
fetal lactate concentrations [16]. Extrapolation from
animal studies must be carefully considered due to
physiological species differences and pharmacological
requirements. Human studies with uncompromised
fetuses have not indicated a negative fetal or
maternal outcome with phenylephrine use, as
demonstrated by the comparable Apgar scores of
the neonates. Vasopressor choice in non-elective
Cesarean sections is still debatable. Phenylephrine
was shown to be as effective as ephedrine in non-
elective cases in one human study [26]. This differs
from studies with sheep indicating compromised
fetuses better tolerate ephedrine than phenylephrine
[16, 24]. 
In conclusion, both ephedrine and phenylephrine
in the bolus dose of 5 mg and 100 µg respectively
can safely be employed to combat hypotension in
patients undergoing elective lower segment
Cesarean section under spinal anesthesia. Further
studies should be considered to evaluate the
incidence of fetal acidosis and comparative fetal
hemodynamics as a result of treating maternal
hypotension. In addition, though both vasopressors
reliably raised maternal blood pressure, the clinical
significance of tachycardia, bradycardia and
intraoperative nausea and vomiting should not be
overlooked.
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